Accession Number: | 0001209191-22-032204 |
Date: | 2022-05-24 |
Issuer: | ATYR PHARMA INC (LIFE) |
Original Submission Date: |
SHUKLA SANJAY
3545 JOHN HOPKINS COURT, SUITE #250
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 2.81 | 2022-05-24 | deemed execution date | A | 516,280 (a) | 2032-05-24 | common stock 516,280 | $2.81 | 516,280 | direct |
ID | footnote |
---|---|
f1 | the shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning june 24, 2022, such that this option will be fully exercisable on may 24, 2026. this option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. |